Drugs

Kisunla (donanemab) is a new IV anti-amyloid beta-directed monoclonal antibody for adults with mild cognitive impairment or mild dementia due to Alzheimer's disease. 

Based on a recent ISMP Canada safety bulletin, which of the following main themes have led to medication incidents associated with newer insulin products?

ISMP Canada shares recommendations to enhance safe use of biosimilar insulins, and faster-acting, longer-acting and higher-concentration insulin analogues.

Canada is the first of the G-7 countries to authorize generic semaglutide.

Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries and conferences dedicated to the mind-altering substances. Now add one more business to the list: psychedelic retreats.

Study examines the risk of all-cause mortality with approved and off-label pharmacotherapies for irritable bowel syndrome (IBS).

The federal agency says it continues to review eight other generic semaglutide submissions from other companies.

Since most medications are taken daily, doses outside that interval have a lot of error potential.